SGS M-Scan News
2011
Newsletters - June 2011
01. Jun 2011
Glycosylation is one of the mostly widely observed and structurally diverse forms of Post Translational Modifications of proteins. The diversity of structure and the significance of the glycosylation means that close attention must be paid to the nature of glycans on any glycoprotein biopharmaceutical and is an important issue for regulatory agencies.
The featured article this quarter focuses on: “ How do you perform glycoprotein characterization to comply with the ICH Q6B guidelines”? You can read the article at http://www.sgs.com/lsnewsqc/lsnewsqc-june-2011-issue/glycosylation-of-proteins-structure-function-and-analysis.htm
For more information about SGS M-Scan services on “Glycoprotein Analysis” contact us by email or visit our webpage.
2011
Newsletters - March 2011
01. Mar 2011
The first newsletter in 2011 opens with a review article on the application of mass spectrometry for protein analysis by Dr. Howard Morris, Emeritus Professor Imperial College London and M-Scan Founder.
This short paper gives the essential background to an understanding of biopharmaceutical characterization by mass spectrometry and its importance in accelerating the processes leading to the approval by the regulator of well- characterized new drugs. Products involved include monoclonal antibodies, hormones and cytokines, and the new generation of Biosimilars and Biobetters resulting from patent expiration of the originator products. Subsequent newsletters from SGS M-Scan experts will provide more detail of the glycosylation, disulfide bridge assignment and monoclonal antibody specifics of the MS characterization protocols offered by SGS M-SCAN to serve its clients’ needs.
You can read the article at http://www.sgs.com/lsnewsqc/lsnewsqc-march-2011-issue/protein-and-glycoprotein-characterisation-by-mass-spectrometry.htm
For more information about SGS M-Scan services on “Protein Analysis” contact us by email or visit our webpage.
2011
Name Change
31. Jan 2011
We are proud to announce that we are changing company name from M-Scan to SGS M-Scan.
The name change is due to the recent acquisition by SGS, the World’s leading inspection, verification, testing and certification company. Together, we will continue to provide our clients with the same high quality services, without interruption, on which we have built our reputation within the industry.
Are there any other changes?
The only change will be an increased battery of services.
Management will remain the same and all contact details (phone numbers and emails) will remain the same, but you may notice responses are sent from our new email domains firstname.lastname@sgs.com. Please continue to liaise with your SGS M-Scan representative.
2010
SGS Group acquires M-Scan Group
01. Nov 2010
The M-Scan Group is pleased to announce its acquisition by SGS, the World’s leading inspection, verification, testing and certification company. Our founder, Professor Howard Morris, comments “We see compelling synergies between the respective current testing activities of M-Scan and SGS. This is an exciting opportunity to provide our customers with an enhanced range of services — complementing our core strengths in advanced mass spectrometric and chromatographic analysis in the fields of biopharmaceutical characterisation, oil/petroleum analysis and environmental monitoring. I look forward with enthusiasm to continuing my consultancy / advisory role within the new framework.”
SGS is recognised as the global benchmark for quality and integrity, employing 59,000 people and operating a network of more than 1,000 offices and laboratories around the World. The four laboratories of the M-Scan Group will join SGS’ existing global Life Science Services network of 14 laboratories in the USA, Belgium, Canada, China, France, Germany, India, Singapore, Taiwan and Thailand.
Dr Andrew Reason remains as Managing Director of M-Scan Ltd and GmbH, Dr. Mark Rogers remains Director of M-Scan INC, Dr. Luc-Alain Savoy remains Director of M-Scan SA and Dr Fiona Greer continues as Global Director of QA/QC and Marketing. We will continue to provide the same high quality services to our valued customers without interruption, and the only expected change will be an enhancement of the range of services we can provide. All CDAs / Contracts with M-Scan remain valid. Our contact details remain exactly the same.
Together M-Scan and SGS will continue to provide you with World-leading bespoke chemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on Mass Spectrometry and Chromatography.
Please do not hesitate to contact us if you would like any further information regarding this exciting development.
2010
FDA Audit at M-Scan Ltd
05. Oct 2010
M-Scan Ltd (Wokingham, UK) was successfully audited by the FDA in connection with a client submission. No written objections were received.
2010
GMP re-inspection at M-Scan SA
26. Aug 2010
M-Scan SA (Geneva) successfully completed a routine inspection for GMP compliance. Swissmedic will shortly issue an updated GMP certificate.
2010
M-Scan Receives GLP & cGMP Re-Certification
15. Apr 2010
M-Scan received GLP re-certification issued by the MHRA in February 2010 and cGMP
re-certification issued by the MHRA in March 2010 for its Wokingham site located in the United Kingdom.
This certification provides an invaluable benefit to our clients by reaffirming our dedication to providing compliant based analysis to support regulatory submissions and clinical studies.
M-Scan is proud of its re-certification and believes this to be in line with our commitment to quality.
2010
M-Scan is pleased to announce the acquisition of new instruments
11. Mar 2010
The M-Scan Group is pleased to announce the following recent instrument acquisitions in our laboratories worldwide to expand our already impressive capabilities.
M-Scan Ltd (UK) has purchased another new mass spectrometer – the latest Waters Xevo QTof MS enabling greater sensitivity and improved run times, whilst the newly installed software allows for improved comparison of data and better interpretation.
M-Scan SA (Switzerland) has also added a new instrument to their laboratory facilities. The new mass spectrometer, a Waters Q-Tof micro will be the second such instrument available at their premises, and will increase their existing capabilities for sample analysis.
M-Scan Inc (US) has recently acquired a TurboMatrix Headspace 40 Trap for their GC-MS instrument providing improved performance and higher sensitivity. The new system will increase capacity and capability of analyzing volatile compounds at the lowest possible detection levels.
These new acquisitions reaffirm the commitment of the M-Scan Group to provide the best quality analytical services to our clients.
2009
M-Scan Announces Apple iPod touch Prize Draw Winner
01. Dec 2009
M-Scan announced today the winner of the “iPod touch 8GB” of the recent contest to celebrate its 30th anniversary and the launch of M-Scan’s new website. The winner was selected randomly by Professor Anne Dell at Imperial College London who was recently appointed CBE in the 2009 Birthday Honours.
Many congratulations to the winner from Laupheim, Germany.
Contact m-scan@m-scan.com for further information.
(Apple iPod touch is a trademark of Apple Inc.)
2009
Gehen Sie auf Schatzsuche!
22. Oct 2009
M-Scan feiert sein 30-jähriges Firmenjubiläum. Aus diesem Anlass haben wir unsere Website neu gestaltet und erweitert, um Ihnen einen besseren Zugang zu unserem umfangreichen Service zu ermöglichen.
Gehen Sie mit uns auf Schatzsuche mit der Chance einen Apple iPod touch 8GB zu gewinnen!
Wir haben auf dieser Website 3 iPod touch Bilder versteckt. Notieren Sie die Buchstaben neben den Bildern um ein Lösungswort zu erhalten.
Um am Gewinnspiel teilzunehmen senden Sie das Lösungswort (englisch) einfach an treasure-hunt@m-scan.com. Der Teilnahmeschluss ist der 27.Nov.2009.
Der glückliche Gewinner wird per Email benachrichtigt.
(Apple iPod touch is a trademark of Apple Inc.)
